HKSE:02135 (China)
Â
Ordinary Shares
HK$
0.12
+0.0030 (+2.59%)
Aug 21
Business Description
Raily Aesthetic Medicine International Holdings Ltd
ISIN : KYG7356A1058
Share Class Description:
HKSE:02135: Ordinary SharesTotal Employee Number:
264Compare
Compare
Traded in other countries / regions
02135.Hong Kong IPO Date
2020-12-28Description
Raily Aesthetic Medicine International Holdings Ltd is an investment holding company. The company were principally engaged in the provision of aesthetic medical services, sale of aesthetic medical equipment products and provision of consulting services. The group is organized into three reportable operating segments namely Aesthetic medical services comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others; Aesthetic medical equipment products comprise principally sales of collagen injection products, surgical implants and aesthetic medical skincare products; Consulting services comprise principally management consulting services of which majority of revenue comes from Aesthetic medical services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.98 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | 2.35 | |||||
Interest Coverage | 2.45 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 0.31 | |||||
Beneish M-Score | -3.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.1 | |||||
3-Year EBITDA Growth Rate | 71 | |||||
3-Year Book Growth Rate | -17.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.8 | |||||
9-Day RSI | 66.17 | |||||
14-Day RSI | 62.56 | |||||
3-1 Month Momentum % | -30.94 | |||||
6-1 Month Momentum % | -36 | |||||
12-1 Month Momentum % | -20 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.77 | |||||
Quick Ratio | 0.71 | |||||
Cash Ratio | 0.46 | |||||
Days Inventory | 32.33 | |||||
Days Sales Outstanding | 2.85 | |||||
Days Payable | 23.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5 | |||||
Shareholder Yield % | -18.9 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.06 | |||||
Operating Margin % | 3.55 | |||||
Net Margin % | 1.04 | |||||
EBITDA Margin % | 13.38 | |||||
FCF Margin % | 13.07 | |||||
OCF Margin % | 19.44 | |||||
ROE % | 1.92 | |||||
ROA % | 0.82 | |||||
ROC (Joel Greenblatt) % | 3.74 | |||||
ROCE % | 2.47 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.75 | |||||
PE Ratio without NRI | 29.75 | |||||
Price-to-Owner-Earnings | 3.49 | |||||
PS Ratio | 0.32 | |||||
PB Ratio | 0.57 | |||||
Price-to-Tangible-Book | 0.99 | |||||
Price-to-Free-Cash-Flow | 2.43 | |||||
Price-to-Operating-Cash-Flow | 1.67 | |||||
EV-to-EBIT | 17.26 | |||||
EV-to-EBITDA | 1.94 | |||||
EV-to-Revenue | 0.26 | |||||
EV-to-FCF | 1.98 | |||||
Price-to-GF-Value | 0.85 | |||||
Price-to-Projected-FCF | 5.95 | |||||
Price-to-Graham-Number | 1.19 | |||||
Earnings Yield (Greenblatt) % | 5.79 | |||||
FCF Yield % | 41.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Raily Aesthetic Medicine International Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 208.261 | ||
| EPS (TTM) (HK$) | 0.004 | ||
| Beta | -0.1139 | ||
| 3-Year Sharpe Ratio | -1.01 | ||
| 3-Year Sortino Ratio | -1.09 | ||
| Volatility % | 36.67 | ||
| 14-Day RSI | 62.56 | ||
| 14-Day ATR (HK$) | 0.003755 | ||
| 20-Day SMA (HK$) | 0.10335 | ||
| 12-1 Month Momentum % | -20 | ||
| 52-Week Range (HK$) | 0.092 - 0.196 | ||
| Shares Outstanding (Mil) | 557.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Raily Aesthetic Medicine International Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Raily Aesthetic Medicine International Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| 0.2:1 Stock Split | 2024-03-19 | 0.33 (+7.14%) |
Show
Entries
Raily Aesthetic Medicine International Holdings Ltd Frequently Asked Questions
What is Raily Aesthetic Medicine International Holdings Ltd(HKSE:02135)'s stock price today?
The current price of HKSE:02135 is HK$0.12. The 52 week high of HKSE:02135 is HK$0.20 and 52 week low is HK$0.09.
When is next earnings date of Raily Aesthetic Medicine International Holdings Ltd(HKSE:02135)?
The next earnings date of Raily Aesthetic Medicine International Holdings Ltd(HKSE:02135) is .
Does Raily Aesthetic Medicine International Holdings Ltd(HKSE:02135) pay dividends? If so, how much?
Raily Aesthetic Medicine International Holdings Ltd(HKSE:02135) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Raily Aesthetic Medicine International Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers